Tagged: clinical trial
The 1987 Paper That Invented GABA Oolong Was About Blood Pressure
The tea sold today for stress relief and better sleep began as a 1987 Japanese food-science paper aimed at hypertension. That claim has real, if modest, human trial evidence behind it. The calm claim now on the label rests on thinner proof, and on a molecule no human study has shown reaches the brain at all.
The oolong weight-loss trials measured hours of fat-burning, not pounds
No systematic review of oolong and weight loss exists, only two small human trials. Here is what those trials, and the closest systematic review that does exist (green tea's), actually measured, in kilograms, not adjectives.
The Oolong Diabetes Trial Everyone Cites Had One Funder
A 2003 trial found oolong tea cut blood sugar by nearly a third in diabetic patients. It was run by a beverage maker's own research lab, the one independent repeat found nothing, and a large cohort found the opposite. Here is what actually holds up.
Oolong and the Clinical Trial
The evidence behind oolong's health claims runs from a 76,979-person cohort to a 20-person industry-run crossover, and the two are not the same kind of proof. The Order's standing method for reading a trial before trusting it: sample size, funding, statistical versus practical significance, and how much a single study should ever be allowed to settle a question.
Oolong and Health
What the published research on oolong tea actually measures, not what the label copy claims. The trial and cohort evidence on the heart, blood sugar, weight, and bone, how partial oxidation changes the chemistry those trials test, and how to read a small positive trial against a large null one.